Drug development in Alzheimer's disease: the contribution of PET and SPECT

• Main Authors: Lieven Denis Herwig Declercq (Author), Rik eVandenberghe (Author), Koen eVan Laere (Author), Alfons eVerbruggen (Author), Guy eBormans (Author)
• Format: Book
• Published: Frontiers Media S.A., 2016-03-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Clinical trials aiming to develop disease-altering drugs for Alzheimer's disease (AD), a neurodegenerative disorder with devastating consequences, are failing at an alarming rate. Poorly defined inclusion- and outcome criteria, due to a limited amount of objective biomarkers, is one of the majo...